Diabetic-macular-edema

Do you have an idea for The New Times to cover? Submit it here!
Search Results for "Diabetic-macular-edema" (6 articles)
A section of Kigali Central Business District at Imbuga City Walk in Nyarugenge District, on Monday, May 11. Photo by Craish Bahizi

Rwanda’s emerging role in global cancer innovation

Tuesday, May 12, 2026
Rwanda has approved BioUcenta™, a lower-cost drug similar to Lucentis® (ranibizumab), to treat diabetic macular edema
Health

Rwanda FDA approves Africa’s first affordable eye drug

Tuesday, October 21, 2025
L-R: Menghis Bairu, the President and CEO of Bio Usawa, Delese Mimi Darko, the Managing Director of the African Medicines Agency, and Nicaise Ndembi, the Deputy Director General of the Africa Regional Office of the International Vaccine Institute. All three organizations are headquartered in Kigali.

How Kigali is becoming Africa’s biopharma capital

Saturday, July 05, 2025
No Image
play icon
Health

Rwanda to host Africa’s first eye and cancer drug facility

Friday, March 14, 2025
Menghis Bairu, the Chief Executive Officer of Bio Usawa and Francis Gatare, Rwanda Development Board's Chief Executive Officer in February 2024. Courtesy
Health

Rwanda, Bio Usawa ink deal to manufacture affordable eye treatments in Africa

Friday, November 22, 2024
People with diabetes can have an eye disease called diabetic retinopathy. /Net photo

The worldwide epidemic of diabetic retinopathy

Saturday, November 03, 2018